Company news
Hunan Warrant Pharmaceutical Co., Ltd. news in 2025
Hunan Warrant Pharmaceutical Co., Ltd.'s news releases, calls and decks from 2025, newest first.
Announcement on Resolutions of the 7th Extraordinary Meeting of the 4th Board of Directors
December 26, 2025
Announcement on Election of Employee Representative Directors for the 4th Board of Directors
December 24, 2025
Announcement on Changing Registered Capital, Canceling Board of Supervisors, Adjusting the Number Directors of the Board of Directors, Amending the "Articles of Association", Handling Industrial and Commercial Change Registration, and Formulating and Revising Some Governance Systems
December 10, 2025
Announcement on Resolutions of the 3rd Meeting of the 4th Board of Directors
October 30, 2025
Announcement on Voluntary Disclosure of Prospective Winning in the National Centralized Drug Procurement
October 28, 2025
Announcement on Progress in Co-investment with Related Parties in Capital Increase to Joint-stock Company and Related Party Transactions
September 24, 2025
Announcement on Shareholding Reduction Result of Shareholders, Directors and Their Persons Acting in Concert with Over 5% Shares
September 12, 2025
Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Hunan Jurisdiction and Semi-annual Performance Briefing
September 11, 2025
Announcement on Progress in Capital Increase of Holding Subsidiary to Introduce Strategic Investors and Related Party Transactions
September 7, 2025
Indicative Announcement on Changes in Equity Interests Reaching a Multiple of 5% by Shareholders and Directors Holding 5% or More of Shares and Their Persons Acting in Concert
September 3, 2025
Special Report on Semi-annual Deposit, Management and Actual Use of Raised Funds in 2025
August 29, 2025
Announcement on Shareholding Reduction Plan by Shareholders, Directors and Their Persons Acting in Concert with Over 5% Shares
July 27, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
June 27, 2025
Announcement on Voluntary Disclosure of Drugs Passing Consistency Evaluation of Quality and Efficacy of Generic Drugs
June 26, 2025
Announcement on Correction of Announcement on Adjustment and Extension of Some Sub-projects of Investment Projects Financed by Raised Funds
June 13, 2025
Notice on Convening the 1st Extraordinary General Meeting of 2025
June 11, 2025
Announcement on Abnormal Fluctuations in Stock Trading
May 30, 2025
Announcement on Litigation Progress
May 26, 2025
Announcement on Implementation of Dividend Distribution for 2024
May 22, 2025
Announcement on Diluted Immediate Return, Mitigating Measures, and Related Entity Commitments for Issuance of A-shares to Specific Objects in 2024 (Revised Draft)
May 12, 2025